DrugPatentWatch Database Preview

Drugs in Development Information for Asunaprevir

« Back to Dashboard

Summary for Asunaprevir

US Patents	28
International Patents	253
US Patent Applications	41
WIPO Patent Applications	5
Japanese Patent Applications	0
Clinical Trial Progress	Phase 3 (2015-12-01)
Vendors	20

US Patents for Asunaprevir

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Asunaprevir		Hepatitis C virus inhibitors	Bristol-Myers Squibb Company (Princeton, NJ)
Asunaprevir		Hepatitis C virus inhibitors	Bristol-Myers Squibb Company (Princeton, NJ)
Asunaprevir		Hepatitis C virus inhibitors	Bristol-Myers Squibb Company (Princeton, NJ)
Asunaprevir		Hepatitis C virus inhibitors	Bristol-Myers Squibb Company (Princeton, NJ)
Asunaprevir		Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-is- oquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolina- mide	Bristol-Myers Squibb Company (Princeton, NJ)
Asunaprevir		Hepatitis C virus inhibitors	Bristol-Myers Squibb Company (Princeton, NJ)
Asunaprevir		Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-is- oquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcycl- opropyl)-L-prolinamide	Bristol-Myers Squibb Company (Princeton, NJ)

International Patents for Asunaprevir

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Asunaprevir	Argentina	040080	2022-05-20
Asunaprevir	Argentina	087051	2022-05-20
Asunaprevir	Argentina	090649	2022-05-20
Asunaprevir	Austria	506104	2022-05-20
Asunaprevir	Australia	2003241510	2022-05-20
Asunaprevir	Brazil	0311132	2022-05-20
Asunaprevir	Canada	2486308	2022-05-20